Gyrolab® systems are open platforms used for rapid development and processing of miniaturized immunoassays in quantitating proteins to advance biotherapeutic programs. Based on a flow-through affinity column format, Gyrolab technology automates assay workflows with minimal matrix interference at nanoliter volumes within a CD consumable under the control of Gyrolab instruments and Gyrolab Control software. Gyrolab systems produce high quality data in under an hour, enabling data driven decisions for critical timelines to support all stages of biotherapeutic development.
Biotherapeutic development is currently challenged by increasing costs, data quality, slow turnaround time and delays due to assay development and validation. Bioanalytical assays for biotherapetics require precise protein quantitation from complex matrices (e.g. serum or cell culture). Gyrolab systems support a wide range of applications requiring performance, productivity, throughput with time constraints for critical workflows throughout the entire drug development process.
blockOneRows: 3; blockTwoRows: 3; blockRowCount: 3
“Better Science – fewer animals” Nanoliter-scale assays reduce animal usage in preclinical studies
Extract maximum biomarker/PD information from limited sample volumes
Automated sample pretreatment and immunoassay workflow at nanoliter-scale reduces hands-on time
Design and evaluate in solution affinity runs using non-modified substances
Broad dynamic range ensures high-sensitivity quantification throughout the development process
Rapid quantification of contaminants enables data-driven decisions to be made throughout the biotherapeutics workflow